| 1. | The developments of synthesis of isocarbostyril
异喹诺酮的合成进展 |
| 2. | Induction and mechanisms of cross - resistance to quinolones in ureaplasma urealyticum
体外诱导解脲脲原体对喹诺酮类药物交叉耐药的研究 |
| 3. | Clinical analysis on adverse reaction of central nervous system induced by fluoroquinolone
氟喹诺酮类药物致中枢神经系统不良反应的临床分析 |
| 4. | Comparison of hepatic toxic injury induced by concomitant use of fluoroguinolones and antituberculotics in mice
氟喹诺酮类联用抗结核药肝毒性比较 |
| 5. | Rapid detection of the mutations of resistance - fluoroquinolone neisseria gonorrhoeae gene by a dna microarray
快速检测淋球菌耐喹诺酮类药物基因突变 |
| 6. | Analysis of the residuals of trace quinolones in the pig viscera by mekc using sweeping technique
猪脏器中痕量喹诺酮类药物的胶束毛细管电泳在线富集技术检测 |
| 7. | Studies on interaction of new medicine of quinolone - class with hsa and bsa by using fluorescence enhancement and fluorescence quenching theory
用荧光猝灭和荧光加强两种理论研究喹诺酮类新药与白蛋白的作用 |
| 8. | It was shown that there was a relationship between the degree of quinolone - resistance to clinical poultry salmonella and the amino acid mutations in qrdr of the gyra gene
由此表明禽源沙门氏菌gyra基因qrdr区的变异与菌株对喹诺酮类药物的耐药性有一定相关性。 |
| 9. | Fluoroquinolones enterprises in china need to revise product lines reasonably based on product strategy and analyzing the competition trends so as to win more superiority in competition
氟喹诺酮类原料药企业需要结合自身产品战略，分析竞争形势，合理调整产品线，以获得更强竞争优势。 |
| 10. | Among outpatient cases , the rate of fluoroquinolone use increased from 35 % to 61 % , whereas the rate of trimethoprim - sulfamethoxazole use decreased from 53 % to 32 % oer the 5 - year period ( p < . 01 )
门诊病人中氟喹诺酮运用在5年期间从35增加到61 ，而甲氧苄氨嘧啶的运用率从53减少至32 ( p < . 01 ) 。 |
